We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-12.04%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.36%
AUM
$209M
AUM Growth
-$34.7M
Cap. Flow
-$2.63M
Cap. Flow %
-1.26%
Top 10 Hldgs %
32.75%
Holding
116
New
–
Increased
22
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$2.71M
2
TROW icon
T. Rowe Price
TROW
+$1.22M
3
WBA
Walgreens Boots Alliance
WBA
+$81.8K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$50.5K
5
PRLB icon
Protolabs
PRLB
+$32.5K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.05M
2
NVDA icon
NVIDIA
NVDA
+$327K
3
ISRG icon
Intuitive Surgical
ISRG
+$299K
4
DIS icon
Walt Disney
DIS
+$221K
5
AFL icon
Aflac
AFL
+$214K

Sector Composition

Rank Sector Weight
1 Healthcare 30.84%
2 Technology 29.7%
3 Industrials 13.23%
4 Financials 7.72%
5 Consumer Discretionary 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$72.7B
$2.88M 1.38%
10,934
-65
-0.6% -$16.7K
PYPL icon
27
PayPal
PYPL
$51.1B
$2.84M 1.36%
40,719
+31,292
+332% +$2.71M
JNJ icon
28
Johnson & Johnson
JNJ
$619B
$2.75M 1.32%
15,492
-142
-0.9% -$25.3K
MRK icon
29
Merck
MRK
$316B
$2.71M 1.3%
29,699
-249
-0.8% -$22.1K
ABBV icon
30
AbbVie
ABBV
$430B
$2.68M 1.29%
17,500
+3
+0% +$458
ADBE icon
31
Adobe
ADBE
$104B
$2.48M 1.19%
6,780
-10
-0.1% -$4.07K
DLB icon
32
Dolby
DLB
$5.71B
$2.42M 1.16%
33,842
+2
+0% +$151
BEN icon
33
Franklin Resources
BEN
$17.3B
$2.41M 1.16%
103,560
+18
+0% +$460
LOW icon
34
Lowe's Companies
LOW
$122B
$2.37M 1.13%
13,543
+2
+0% +$386
PEP icon
35
PepsiCo
PEP
$189B
$2.36M 1.13%
14,181
-322
-2% -$54.2K
WMT icon
36
Walmart Inc
WMT
$892B
$2.21M 1.06%
54,663
-144
-0.3% -$6.64K
EBS icon
37
Emergent Biosolutions
EBS
$272M
$2.19M 1.05%
70,588
-37
-0.1% -$1.26K
SYK icon
38
Stryker
SYK
$129B
$2.11M 1.01%
10,597
-14
-0.1% -$3.29K
ABT icon
39
Abbott
ABT
$187B
$1.98M 0.95%
18,238
+1
+0% +$114
TEVA icon
40
Teva Pharmaceuticals
TEVA
$40.5B
$1.87M 0.9%
248,516
+5,800
+2% +$50.5K
ITW icon
41
Illinois Tool Works
ITW
$84.7B
$1.82M 0.87%
9,991
+1
+0% +$200
VOE icon
42
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
$1.77M 0.85%
13,663
-421
-3% -$59.6K
KO icon
43
Coca-Cola
KO
$373B
$1.75M 0.84%
27,735
-95
-0.3% -$6.02K
MDT icon
44
Medtronic
MDT
$110B
$1.67M 0.8%
18,647
+3
+0% +$304
DOX icon
45
Amdocs
DOX
$6.28B
$1.64M 0.78%
19,625
+2
+0% +$165
TDY icon
46
Teledyne Technologies
TDY
$31.9B
$1.62M 0.78%
4,317
– –
ADI icon
47
Analog Devices
ADI
$185B
$1.62M 0.78%
11,074
-698
-6% -$110K
HD icon
48
Home Depot
HD
$348B
$1.49M 0.72%
5,440
– –
VYM icon
49
Vanguard High Dividend Yield ETF
VYM
$82.3B
$1.41M 0.67%
13,827
-400
-3% -$43.3K
INTC icon
50
Intel
INTC
$505B
$1.4M 0.67%
37,341
-14
-0% -$606
1
2
3 4 5

Similar funds

FAL
Focused Alpha LLC Denver, Colorado $324M AUM
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return

AIMZ Investment Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, AIMZ Investment Advisors held 116 positions worth $209M, down 14% from $243M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

AIMZ Investment Advisors's Q2 2022 filing shows 22 increased, 47 reduced and 7 closed positions. The largest sale was GSK, an estimated $4.05M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • AIMZ Investment Advisors added most to PayPal in Q2 2022, an estimated $2.71M increase.
  • AIMZ Investment Advisors's biggest Q2 2022 reduction was CDK Global, Inc., cutting an estimated $180K.
  • AIMZ Investment Advisors fully exited GSK in Q2 2022, selling an estimated $4.05M.
  • AIMZ Investment Advisors's ten largest holdings make up 33% of its $209M portfolio in Q2 2022.
  • AIMZ Investment Advisors opened 0 new positions and closed 7 in Q2 2022.
  • AIMZ Investment Advisors's portfolio value fell 14% quarter-over-quarter to $209M.

Based on AIMZ Investment Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.